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Introduction
Depressive symptoms are common in patients hospitalized 
for coronary heart disease (CHD) or revascularization 
interventions, with estimates ranging between 30 and 
40 percent (Herrmann-Lingen and Buss, 2002; Lespérance 
and Frasure-Smith, 2000). In addition, depression disorders 
are reportedly prevalent in between 15 and 20 percent of 
CHD patients, indicating substantially higher prevalence 
than physically healthy populations (Härter et al., 2007). 
Moreover, the deleterious impact of depressive symptoms 
on prognosis, all-cause mortality, quality of life, and health 
care costs is well documented, representing a major public 
health burden (Barth et al., 2004; Baumeister and Härter, 
2005; Härter et al., 2007). Consequently, several learned 
cardiology societies’ guidelines recommend that all CHD 
patients should be routinely screened for depression after 
an acute cardiac event (e.g. American Association of 
Cardiovascular and Pulmonary Rehabilitation, 2004; 
Colquhoun et al., 2013; Giannuzzi et al., 2003; Ladwig 
et al., 2014; Piepoli et al., 2010). However, depression 
interventions in CHD patients have not yielded universally 
positive results with respect to depression remission and 
freedom from CHD events (e.g. Glassman et al., 2002; 
Writing Committee for the Enhancing Recovery in 
Coronary Heart Disease (ENRICHD) Investigators, 
Baumeister et al., 2011; Berkman et al., 2003), raising 
questions about the nature of depressive symptoms post 
cardiac events, the appropriate timing of interventions, and 
who would benefit most from interventions.
One possible reason for the lack of significant impact 
upon such interventions on CHD events is fluctuation of 
depressive symptoms (e.g. spontaneous remission, worsen-
ing depression) following cardiac events, thus obscuring 
the effects of interventions (cf. Schrader et al., 2004). For 
example, Kop (2012) argues that relapsing and treatment 
resistant depression provides an unresolved clinical 
dilemma in CHD patients, thus necessitating further inves-
tigation. Conversely, Lespérance and Frasure-Smith (2000) 
point out that a significant proportion of comorbid depres-
sion-CHD patients have a relatively rapid and spontaneous 
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remission and do not require an intervention. Consequently, 
it is crucial to identify characteristics of CHD patients with 
persistent depression as well as those with sustained remis-
sion to better inform clinical practice and furthermore, to 
inform whom to include in clinical depression trials.
The longitudinal fluctuations in depression classes fol-
lowing cardiac events have been reported in two previous 
Australian studies. Schrader et al. (2004, 2006) showed that 
although the crude proportion of mild and moderate depres-
sion was similar between baseline, 3 and 12 months, there 
was considerable fluctuation at an individual level, empha-
sizing the importance of intra-individual variation. 
Specifically, only 50 percent of those who were depressed 
measured by the Centre of Epidemiology Scale for 
Depression (CES-D) during hospitalization remained 
depressed at 3 and 12 months while incident depression was 
reported in 26 percent of patients. Persistent depression was 
associated with depression scores at baseline, and past his-
tory of emotional problems. Taking a growth mixture mod-
eling approach by examining trajectories after coronary 
artery bypass graft (CABG) surgery, Murphy et al. (2008) 
demonstrated that the majority of patients (72%) showed a 
remitted minor depression; two sub-groups showed either a 
(partially) remitted major depression or a worsening minor 
depression (14% each). In a second cohort, Murphy et al. 
(2013) examined depression and anxiety in 160 patients 
following a cardiac event (myocardial infarction (MI), 
acute coronary syndrome (ACS), percutaneous coronary 
intervention (PCI), CABG), as well as 2 and 6 months after 
hospital discharge. While anxiety scores tended to persist 
over time, in-hospital depression scores resolved for some 
patients (17%) and slightly worsened for others (29%); 
about half of the sample showed no depressive symptoms 
over time. Among others, a mental health history, poor self-
rated health, social isolation, and younger age were predic-
tors for persistent anxiety and worsening depression. 
However, one drawback of these studies is the paucity of 
analogous research in other settings especially in Western 
Europe.
A notable exception is the growth mixture modeling 
study of Romppel et al. (2012) who described individual 
trajectories of depressive classes measured by the Hospital 
Anxiety and Depression Scales (HADS) in over 650 
German cardiac patients. With only two time points at base-
line and 6 years later, they found four latent classes: low 
symptoms (60%), low increase of symptoms (26%), high 
increase (7%), and symptom decrease (7%). The latter was 
associated with female gender. However, this study is lim-
ited by only including two assessment time points.
A more general limitation of studies to date concerns the 
paucity of data concerning key predictors for worsening 
symptoms and persistent depression in CHD that might 
inform clinical treatment initiation. Notwithstanding previ-
ous reports regarding persistent depressive symptoms and 
social isolation (Murphy et al., 2013), it is also plausible 
that other factors such as coping styles and locus of control 
could serve as important moderator variables (Sanjuán 
et al., 2012; Vögele et al., 2012). Conversely, the dearth of 
data regarding sustained remission particularly makes deci-
sions regarding trial inclusion and anti-depressant treat-
ment difficult. Especially the latter might be initiated 
unnecessarily as CHD patients might remit spontaneously. 
Importantly, few studies have investigated serial depression 
classes in relation to major adverse cardiac events 
(MACEs).
In this study, we replicated the approach taken by 
Schrader et al. (2004, 2006) using classes of depression 
defined by clinical cut-offs rather than using a growth mod-
eling approach to identify distinct trajectories. In this way, 
we also wanted to place emphasize on the clinical signifi-
cance of our results. This study advances the understanding 
of CHD and depression in two ways: first, by examining 
predictors of depressive symptom trajectory classes for 
12 months after a cardiac event with a focus on worsening 
symptoms and sustained remission, respectively. Second, 




Patients were recruited by trial staff members on a consecu-
tive basis between October 1998 and June 2000 in seven 
hospitals (acute in-patient or rehabilitation) in northern 
Germany. Eligible patients were those admitted for a first 
cardiac event comprising acute MI, ACS, PCI, CABG. 
Exclusion criteria were age over 75 years, refused written 
consent, or inability to complete questionnaires (e.g. lan-
guage difficulty, visual, or cognitive impairment). Approval 
for the study was obtained from the Ethics Committee of 
the Medical Association Schleswig-Holstein, and all 
patients provided written informed consent.
Measures
The baseline questionnaire was completed 1–3 weeks after 
the cardiac event. Depressive symptoms were assessed 
using the respective subscale of the Symptom Check List-
90-Revised (SCL-90-R; Franke, 2002). This subscale com-
prises 13 items measuring only the affective or cognitive 
aspects of depression, and thus excluding somatic items 
which might be misleading especially in hospitalized 
CABG patients (Tully and Baker, 2012). Missing values for 
individual item responses were replaced with the variable 
mean. Total scores for the SCL-90-R depression subscale 
were calculated according to age and sex adjusted T scores, 
as outlined in the manual (Franke, 2002). In the first 
instance, patients were classified by T scores to either have 
no depressive symptoms (T < 60), mild to moderate 
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depressive symptoms (60 ⩽ T < 70), or severe depressive 
symptoms (T ⩾ 70). For easier interpretation, we then com-
bined the depressive symptom classes, resulting in two 
baseline classes: “no depressive symptoms” and “mild to 
moderate/severe depressive symptoms.” In a next step, we 
defined trajectory classes by watching patient depression 
progress at 3 and 12 months. Trajectories of depression 
were classified as no depressive symptoms, worsening 
depressive symptoms (i.e. elevation in T score ⩾ 60), sus-
tained remission, and persistent depressive symptoms. 
Patients who did not fit the four mentioned classes were 
excluded from further analyses as they showed an unstable, 
more erratic (off-on/on-off) trajectory.
Coping styles were assessed by a German questionnaire 
measuring cognitive, emotional and behavioral aspects of 
coping with illness (FKV-LIS; Muthny, 1989), locus of 
control was assessed by a questionnaire to survey control 
beliefs concerning disease and health (KKG; Lohaus and 
Schmitt, 1989), and perceived social support was assessed 
by the F-SOZU (Sommer and Fydrich, 1991). Follow-up 
depressive symptom and coping style questionnaires were 
sent via mail at 3 and 12 months after discharge from 
hospital.
Endpoints
MACEs during follow-up were defined as recurrent acute 
myocardial infarction (AMI), ACS, PCI, or CABG between 
baseline and 12 months. Mortality was confirmed from 
patient’s local physician. Other medical data were obtained 
from a questionnaire completed by the hospital physicians 
at baseline, and from the family doctors at follow-up 
(12 months).
Data analysis
Statistical analyses were conducted using Statistical Package 
for the Social Sciences (SPSS)® Version 22.0. Logistic 
regression analyses were performed in order to identify pre-
dictors (e.g. demographic, medical, social, and psychologi-
cal variables from the baseline questionnaire) for trajectories 
of depressive classes. In each case, depression at 12 months, 
sustained remission (vs. persistent depressive symptoms), 
and worsening depressive symptoms (vs. no depressive 
symptoms) were employed as dependent variables. Age and 
sex were forced into regression models considering these 
demographic variables are related to depression and cardiac 
outcome (Tully et al., 2015). Otherwise, only covariates 
yielding statistical significant bivariate associations p < 0.05 
with the outcome variables (trajectory classes) were entered 
into the analyses. Major adverse cardiac outcome (binary 
coded) was assessed with the Chi-square statistic in order to 
identify associations with trajectory classes of depression. 
All statistical tests were two-tailed with significance defined 
as p < 0.05.
Results
Sample descriptive characteristics
Initially, 310 patients were recruited, and 252 patients (81%) 
returned the follow-up questionnaires at 3 and 12 months. 
Analysis of attenuation showed that drop-outs were younger, 
and their cardiac status was not significantly different from 
study completers. Table 1 shows baseline patient demographic 
and clinical characteristics of completers. Average age of the 
patients in the sample was 58 years. One-third was female, 
approximately 75 percent were married, and almost 40 percent 
had more than 9 years of schooling. About two-thirds of 
patients were admitted to hospital following MI, 29 percent 
had undergone CABG, and 8 percent received PCI.
Depressive symptom classes over 12-month 
follow-up
At baseline, prevalence rates of depression classes were 
45 percent for “no depressive symptoms,” and 32 or 23 per-
cent for the categories “mild to moderate depressive symp-
toms” and “severe depressive symptoms,” respectively. These 
proportions were almost identical at all time points (Figure 1).
For easier interpretation, we had dichotomized baseline 
depression scores into patients who either experienced no 
depressive symptoms or mild to moderate/severe depressive 
Table 1. Baseline patient demographic and clinical 
characteristics.





 Male 169 67.1
 Female 83 32.9
Marital status
 Single 18 7.2
 Married 193 76.9
 Divorced/separated 24 9.5
 Widowed 16 6.4
Years of schooling
 Up to 9 years 148 59.9
 More than 9 years 95 38.5
 No graduation 2 0.8
Type of cardiac event
 ACS/MI 159 63.9
 CABG 71 28.5
 PCI 19 7.6
SD: standard deviation; ACS: acute coronary syndrome; MI: myocardial 
infarction; CABG: coronary artery bypass graft; PCI: percutaneous 
coronary intervention.
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symptoms. While proportions remained stable, individual 
patient trajectories did not. Collectively, 27 percent (69/252) of 
the patients switched from one class of depression severity to 
another during the first 3 months, and approximately 40 percent 
(99/252; including patients with erratic trajectories) switched 
between depressive symptom classes over the 12-month 
follow-up.
We were able to classify 79 percent of the sample (199/252) 
into the four stable trajectories of depressive symptoms 
(Figure 2). A total of 30 percent (34/114) of those not initially 
depressed were found to report depressive symptoms at 
3 months, reducing to 20 percent (23/114) by 12-month fol-
low-up, thus constituting the worsening depressive symptoms 
group. Out of the 138 patients (55%) with depressive symp-
toms at baseline, 75 percent (103/138) still showed depressive 
symptoms at 3 months, and 63 percent (87/138) remained 
depressed by 12 months, constituting the persistent depressive 
symptoms group. In all, 17 percent (23/138) showed a tran-
sient and sustained remission which had resolved at 3 months 
and did not recur. Out of the 114 patients (45%) with no 
Figure 1. Prevalence rates within each depression category at all three time points (N = 252).
Figure 2. Trajectories of depression symptom classes over 12 months.
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depressive symptoms at baseline, 70 percent (80/114) stayed 
free of depression at 3 months, and 58 percent (66/114) con-
tinued reporting no depressive symptoms at 12 months, con-
stituting the no depression group. Trajectory means are 
pictured in Figure 3. The remaining 21 percent (53/252) of the 
sample showed more erratic (off-on/on-off) trajectories (not 
represented in Figures 2 and 3).
Regression model to determine predictors of 
depression class over time
Predictors for persistent depressive symptoms were baseline 
depression scores and low social support (Table 2). A sus-
tained remission was associated with female gender, CABG 
at baseline assessment, and low depressive coping styles. 
Females had a fourfold greater chance of depression remis-
sion, and probability of diminishing symptomatology in 
patients following CABG was six-fold compared to patients 
following AMI or PCI. A worsening course of depressive 
symptoms over time was associated with higher depression 
scores at baseline, and lower baseline trust in physicians 
measured by three items (“strictly following medical advice,” 
“having confidence in the doctors,” and “distrusting doctors; 
looking for another doctor to confirm diagnosis”).
Depressive symptom classes and MACE
Major cardiac events were more frequent in patients with 
persistent depressive symptoms versus those with sustained 
remission (χ2 = 5.99, df = 1, p = 0.014); 29 percent of those in 
Figure 3. Trajectory means (only patients remaining stable from 3 to 12 months).
Table 2. Results of logistic regression analyses, odds ratios (95% CI).
Predictor Depression at 12 months Transient depressiona Worsening symptomsb
Depression score at baseline 1.07* (1.03; 1.11) 0.94 (0.84; 1.06) 1.15* (1.02; 1.30)
Gender 0.78 (0.40; 1.49) 5.58* (1.33; 23.45) 1.78 (0.40; 7.82)
Age 0.99 (0.96; 1.02) 1.01 (0.93; 1.09) 0.98 (0.90; 1.06)
CABG 0.94 (0.48; 1.84) 6.16* (1.35; 28.15) 2.36 (0.57; 9.81)
PCI 0.67 (0.22; 1.99) 6.06 (0.92; 40.14) 0.71 (0.02; 20.66)
Social support 0.90* (0.83; 0.98) 1.17 (0.98; 1.41) 0.86 (0.70; 1.07)
Internal LOC 1.00 (0.96; 1.05) 0.97 (0.86; 1.08) 1.00 (0.90; 1.11)
External LOC (social) 1.05 (0.98; 1.09) 0.97 (0.88; 1.08) 1.12 (1.00; 1.26)
Depressive coping 1.08 (0.97, 1.21) 0.74* (0.58; 0.96) 0.82 (0.59; 1.12)
Distractive coping 1.05 (0.97; 1.13) 1.07 (0.88; 1.30) 1.17 (1.00; 1.38)
Trust in physicians 0.89 (0.74; 1.07) 1.23 (0.84; 1.81) 0.56* (0.32; 0.96)
Nagelkerke’s R2 0.288 0.430 0.412  
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the former group experienced at least one cardiac event 
while only 4 percent in those with sustained remission 
experienced clinical events. There was no difference as to 
clinical events between those with worsening symptoms 
versus patients with no depressive symptoms at baseline; 
here, 17 and 18 percent of patients, respectively, had at least 
one adverse cardiac event (χ2 = 0.01, df = 1, p = 0.932).
Discussion
First, this study showed that almost 40 percent of patients 
switched depressive symptom classes in the 12 months fol-
lowing their first serious cardiac event (including those 
with more erratic trajectories). It is particularly concerning 
that 44 percent of all observed patients displayed either 
persistent or worsening depressive symptoms. By contrast, 
only 9 percent of patients were found to experience a sus-
tained remission from 3 months onwards. The second 
major finding of this study was the association between 
depressive symptom response and discrete factors, espe-
cially depression at baseline, low social support, and little 
trust in physicians. And third, study results found persons 
with a persistent depressive episode at greatest risk for 
MACE over 12 months. In general, our findings regarding 
depressive symptom trajectories correspond to those 
reported by Schrader et al. (2004, 2006) who utilized a 
similar methodology and time-frame, and also to those 
studies modeling change in cardiac (Murphy et al., 2008, 
2013; Romppel et al., 2012) and non-patient samples 
(Kuchibhatla et al., 2012). Moreover, several studies have 
reported that a new increase in depressive symptoms or 
treatment resistant depression is associated with MACE. 
Collectively, the consistency in findings across studies 
points to the fluctuating nature of depressive symptoms 
after a major cardiac event.
The finding that baseline depression scores were associ-
ated with depression at 12 months is in accordance to ear-
lier studies (Schrader et al., 2006). Depressive coping 
styles, distrust in physicians, and low social support were 
indicators of adverse developments of depressive symp-
toms. In contrast, female gender or antecedent CABG were 
strong predictors of a transient depressive response (=sus-
tained remission). With respect to the former, a more 
favorable course of depression in women was reported by 
Romppel et al. (2012); however, their cohort was only 
assessed on two occasions. Similarly, Bjerkeset et al. 
(2005) found that although women had a high initial risk 
for anxiety and depression after AMI, they showed a sig-
nificant decrease in depressive symptoms after 2 years, 
whereas in men the risk for depression increased. Similarly, 
Shanmugasegaram et al. (2012) found a two times greater 
prevalence of major depression in women than men directly 
following cardiac events, whereas 1 year later men and 
women showed hardly any differences as to depressive 
symptoms any more (Grace et al., 2014).
The association between antecedent CABG and sustained 
remission is potentially related to the invasive nature of the 
surgical procedure, pain, and pronounced physical and activ-
ity limitations (Chapman et al., 2012; Tully and Baker, 
2012). Indeed, evidence suggests that somatic symptoms are 
largely artificially inflated after CABG (Contrada et al., 
2006), and may include somatic complaints following tho-
racic surgery such as loss of appetite, fatigue, or pain. 
However, it is important to note that the depression subscale 
of the SCL-90-R does not include somatic items, thus mak-
ing it suitable for measuring depression in persons with 
physical illnesses. Notwithstanding the absence of somatic 
depressive symptoms, it is likely that early mobility and 
physical improvements following CABG are related to 
decreasing depression symptoms. Along the same line, the 
favorable cardiac prognosis of patients with sustained remis-
sion might be attributable to the antecedent bypass surgery 
and not their emotional wellbeing considering that CABG is 
associated with a favorable prognosis in persons with two or 
more diseased coronary arteries (Hannan et al., 2005).
The importance of identifying persistent depression 
classes is emphasized by the finding that these patients 
reported a significantly higher proportion of adverse car-
diac events during the first 12 months after initial hospitali-
zation. A recent case-control study also showed that 
treatment resistant and insufficiently treated depression 
were associated with increased risk for cardiac events after 
an index AMI (Scherrer et al., 2012). In our sample, more 
than 50 percent of the patients showed symptoms of depres-
sion at every time point over 1 year, about 20 percent of 
them with severe symptoms. Evidently, change in depres-
sion over time may deserve specific monitoring by physi-
cians and mental health specialists alike. The fluctuating 
course of depressive symptoms highlights the possibility 
that persons initially identified with depressive symptoms 
are free from depression some months later and vice versa. 
Indeed, although the American Heart Association guide-
lines (Lichtman et al., 2008) give no clear guidance as to 
the timing of initial depression assessment or follow-up 
monitoring, the recent National Heart Foundation of 
Australia guidelines suggest monitoring 1 month apart in 
the first instance, and annually subsequently (Colquhoun 
et al., 2013).
This study shows that almost one-fifth of the patients 
experienced a sustained remission after the cardiac event 
that resolved during the first 3 months and did not recur. 
This might partly explain the divergence in findings of 
depression interventions such as those initiated within hos-
pital (ENRICHD) versus those targeting sustained depres-
sive episodes (Davidson et al., 2013). Moreover, 
randomization into intervention trials of persons who 
would otherwise spontaneously remit might partly explain 
why trials initiating psychological treatment at least 
2 months after a cardiac event have shown greater benefits 
to depression than those initiating treatment sooner (Linden 
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et al., 2007). Watchful-waiting before commencing anti-
depressive treatment or mental health professional referral 
seems prudent unless immediate treatment is required by 
the particular circumstances of the individual patient 
(Lespérance and Frasure-Smith, 2000; Schrader et al., 
2006). Nevertheless, with respect to clinical trials of depres-
sion interventions, our findings support other scholars’ sug-
gestion that patients should not necessarily be included 
unless depressive symptoms are measured repeatedly 
(Davidson et al., 2006).
The study has several limitations including the inability 
to determine whether patients experienced symptomatic 
depressive symptoms before the index cardiac event. Past 
history of depression was found to increase the risk of inci-
dent depression symptoms (Schrader et al., 2006), but was 
not asked for in this study. Non-fatal clinical cardiac out-
comes were assessed primarily by self-report in survivors, 
thus possibly limiting the validity of the data. Furthermore, 
our findings cannot verify the temporal association between 
depressive symptoms and cardiac events. Specifically, we 
could not establish whether recurring cardiac events pre-
ceded a worsening episode of depressive symptoms. 
Another limitation is surely the modest numbers of patients 
in two of the classes (sustained remission and worsening 
depressive symptoms). Finally, by participating in an obser-
vational psychological study, it is possible that patients 
were prompted to pay attention to their wellbeing and seek 
depression treatment outside the study. This was not moni-
tored and might underestimate depression prevalence. 
Further research should consider these limitations.
In conclusion, this study emphasizes the fluidity of 
depressive symptoms following a cardiac event. Results 
show distinct depression trajectories after a cardiac event 
which were associated with discrete characteristics. The 
collective findings suggest that vigilance to patients’ men-
tal health after a cardiac event is warranted potentially 
through serial assessment of depressive symptoms.
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